Hancock Jaffe Hancock Jaffe
  • Home
  • About
    • Our History
    • Senior Management
    • Board Of Directors
    • Medical Advisory Board Members
  • Products
    • The VenoValve®
    • CoreoGraft® – Bypass Graft
  • Contact
  • Careers
  • Investors
    • Overview
    • Investor Presentation
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
    • Proxy Information
Hancock Jaffe Hancock Jaffe
  • Home
  • About
    • Our History
    • Senior Management
    • Board Of Directors
    • Medical Advisory Board Members
  • Products
    • The VenoValve™
    • CoreoGraft™ – Bypass Graft
  • Contact
  • Careers
  • Investors
    • Overview
    • Investor Presentation
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • Analyst Coverage
    • SEC Filings
    • Corporate Governance
    • Proxy Information

Press Releases

Investors
  • Overview
  • Investor Presentation
  • News / Events
    • Recent News / Events
    • Press Releases
    • Articles & Publications
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Profile
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Overview
    • Quote
    • Charts
    • Historical Data
  • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Proxy Information
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News / Events

  • Recent News / Events
  • Press Releases
  • Articles & Publications
  • IR Calendar
  • Email Alerts

Hancock Jaffe Successfully Completes VenoValve Implantation for First-in-Human Study

Jun 13, 2019

Hancock Jaffe Announces Pricing of Public Offering of Common Stock

Jun 12, 2019

Hancock Jaffe Reports Early Positive Results from First-In-Human VenoValve Study

Jun 7, 2019

Hancock Jaffe Enrolls Two Additional Patients for First-in-Human VenoValve Study

Jun 3, 2019

Hancock Jaffe to Present VenoValve Case Management Report at Expert Venous Management Conference on June 7, 2019

May 28, 2019

Hancock Jaffe Announces Retirement of Board Chairman Yury Zhivilo

May 24, 2019

Hancock Jaffe Expands CoreoGraft Feasibility Study

May 21, 2019

Hancock Jaffe Announces Successful Third Implantation for CoreoGraft Study at Texas Heart Institute

May 1, 2019

Hancock Jaffe Mourns the Loss of Director Marc Robins

Apr 30, 2019

Hancock Jaffe Successfully Completes Four VenoValve Implantations for First-in-Human Study

Apr 11, 2019
RSS
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    Copyright© 2021 by Hancock Jaffe Laboratories, Inc. All Rights Reserved | Terms of Use & Privacy Policy | Designed by Velocidi
    Show / Refresh / Reset / Delete
    Views until show: 5
    Seconds until show: 5
    By using this website, you consent to the use of cookies, as described in our privacy policy.Accept